| Literature DB >> 32778080 |
Tetsuro Ohba1, Hiroshi Yokomichi2, Kensuke Koyama3, Nobuki Tanaka3, Kotaro Oda3, Hirotaka Haro3.
Abstract
ABTSRACT:Entities:
Keywords: Mortality; Osteoporotic vertebral fractures; Serum albumin
Mesh:
Substances:
Year: 2020 PMID: 32778080 PMCID: PMC7418372 DOI: 10.1186/s12891-020-03564-z
Source DB: PubMed Journal: BMC Musculoskelet Disord ISSN: 1471-2474 Impact factor: 2.362
Preoperative characteristics and demographics of patients with OVFa
| Patients with OVF | ( |
|---|---|
| Age at the time of admission, y | 76.3 ± 7.5 |
| Gender, female/male, n | 65/40 |
| BMI (kg/m2) | 22.4 ± 3.3 |
| BMD (%YAM) | 69.7 ± 13.5 |
| Follow-up duration, months | 28.3 ± 31.8 |
| Injured vertebral level (Th10-L2/L3–4) | 77/28 |
| Type of Denis’s classification (A/B/C) | 56/46/3 |
| VP (HA) + PF | 49 |
| BKP | 18 |
| ADF + PF | 38 |
aMean ± standard deviation, unless otherwise indicated
ADF anterior spinal decompression and fusion, BKP balloon kyphoplasty, BMI body mass index, BMD bone mineral density, YAM young adult mean, HA hydroxyapatite, OVF osteoporotic vertebral fractures, PF posterior fixation, VP vertebroplasty
Factors associated with subsequent survival/mortality in patients who survived more than 2 years after surgery
| Characteristic | Died ( | Survived ( | Power | |
|---|---|---|---|---|
| Male gender, n (%) | 11 (57.9) | 16 (28.6) | 0.029* | 0.48 |
| Age, years | 79.1 (7.6) | 75.6 (8.0) | 0.10 | 0.38 |
| BMI, kg/m2 | 21.3 (3.1) | 22.5 (3.0) | 0.15 | 0.31 |
| LVEF, % | 70.3 (9.6) | 71.9 (14.1) | 0.65 | 0.078 |
| Serum albumin, g/dL | 3.4 (0.5) | 3.9 (0.5) | 0.0016* | 0.96 |
| BNP, pg/mL | 45.3 (36.4) | 44.9 (47.2) | 0.98 | 0.050 |
| CCr, mL/min | 49.9 (20.1) | 63.1 (21.6) | 0.021* | 0.65 |
| BMD, %YAM | 63.4 (14.0) | 66.8 (13.4) | 0.47 | 0.15 |
| Follow-up, months | 57.1 (21.2) | 66.4 (25.3) | 0.13 | 0.32 |
| Time from original injury to surgery, months | 4.4 (2.1) | 4.6 (0.49) | 0.21 | 0.090 |
| Type of Denis’s classification (A/B.C) | 12/7 | 34/21 | 0.72 | |
| Surgical procedures | 0.087 | |||
| VP (HA) + PF | 11 (57.9) | 27 (48.2) | ||
| BKP | 2 (10.5) | 16 (28.6) | ||
| ADF + PF | 6 (31.6) | 13 (23.2) | ||
| ASA classification ≥3 | 7 (36.8) | 6 (10.7) | 0.016* | |
| Modified Frankel classification | ||||
| C versus D or E | 8 (47.1) | 21 (38.2) | 0.58 | |
| Estimated blood loss, ml | 168 (155) | 335 (499) | 0.11 | |
| Operative time, min | 162 (98.9) | 201 (114.3) | 0.13 | |
†p value for Fisher’s exact test or Student’s t test
*P < 0.05 in the comparison between groups
Variables are presented as mean (standard deviation) unless noted otherwise
ADF anterior spinal decompression and fusion, ASA American Society of Anesthesiologists, BMD bone mass density, BKP balloon kyphoplasty, n number in group, BMI body mass index, BNP B-type natriuretic peptide, CCr creatinine clearance, HA hydroxyapatite, LVEF left ventricular ejection fraction, PF posterior fixation, VP vertebroplasty, YAM young adult male
Fig. 1Comparisons of blood loss (a) and surgical time (b) among surgical procedures. ADF, anterior spinal decompression and fusion; BKP, balloon kyphoplasty; HA, hydroxyapatite; PF, posterior fixation; VP, vertebroplasty. *P < 0.05; NS = not significant. Data were analyzed using the unpaired t-test
Pre- and postoperative patient VAS scores (lumbar and leg) and Modified Frankel classification
| Preoperative | 1 year after surgery | ||
|---|---|---|---|
| VAS score (lumbar) | 7.4 ± 3.4 | 5.8 ± 3.8 | < 0.05* |
| VAS score (leg) | 6.7 ± 2.8 | 3.4 ± 2.1 | < 0.05* |
| Modified Frankel classification (A/B/C/D/E) | 0/0/44/39/22 | 0/0/28/42/31 | < 0.05† |
*Mean ± standard deviation, unless otherwise indicated
*P < 0.05 in the comparison between groups
†p value for Fisher’s exact test for Modified Frankel classification C versus D or E
VAS visual analog scale
Pre-surgery hazard ratios (95% CI) of mortality based on patient characteristics (N = 105)
| Explanatory variable | Crude | p-value | Adjusted HR† | p-value |
|---|---|---|---|---|
| Male vs female gender | 2.74 (1.17, 6.41) | 0.021 | 1.82 (0.76, 4.40) | 0.18 |
| BMI ≥25 vs 18.5–24.9 kg/m2 BMI ≥25 vs. 18.5–24.9 kg/m2 | 1.45 (0.41, 5.09) | 0.56 | 1.67 (0.44, 6.32) | 0.45 |
| BMI < 18.5 vs 18.5–24.9 kg/m2 BMI < 18.5 vs. 18.5–24.9 kg/m2 | 2.78 (0.99, 7.81) | 0.052 | 2.81 (0.96, 8.25) | 0.061 |
| Serum albumin < 3.5 g/dL | 4.99 (2.00, 12.43) | 0.0006 | 3.37 (1.28, 8.89) | 0.014 |
| CCr < 60 mg/dL | 3.40 (1.15, 10.06) | 0.027 | 1.96 (0.63, 6.05) | 0.25 |
| ASA physical status classification ≥3 | 3.93 (1.68, 9.21) | 0.0017 | 2.36 (0.93, 6.01) | 0.072 |
†Explanatory variables were selected using p < 0.2 in the univariate analysis for crude hazard ratios. All of the variance inflation factors in the multivariate model for the calculation of adjusted hazard ratios were < 1.22, indicating there was no multicollinearity
ASA American Society of Anesthesiologists, BMI body mass index, CCr creatinine clearance, CI confidence interval, HR hazard ratio
Fig. 2Overall survival comparison based on preoperative serum albumin levels (dashed line, ≤3.5 g/dL; solid line, > 3.5 g/dL) using the Kaplan-Meier method